For more than two decades ThermoGenesis Holdings, Inc. has developed and commercialized novel cell processing systems and devices providing global researchers, biomanufacturing organizations and clinicians with highly efficient cell processing devices which helped them to deliver better outcomes in various applications in the cell and gene therapy field.
We offer closed automated solutions for manual steps in the cell manufacturing process. Our flexible automated modules provide performance gains in purifying mononuclear cells, washing contaminants from cell fractions, cell selection, and storage while significantly shortening processing times.
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m. ET RANCHO CORDOVA, Calif., May 13, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, 2021 … Continued
Mindy Wilke-Douglas, currently the Vice President of Operations, has been with ThermoGenesis since 2008. During a company-wide restructuring, she went back to the academic field, but eagerly accepted the opportunity to return when it became available. That’s how much she believes in the mission of the company and in the passion and work ethic that … Continued
Conference Call to be Held on May 13, 2021 RANCHO CORDOVA, Calif., May 6, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2021 … Continued
Throughout our 35-year history, ThermoGenesis Holdings, Inc. has undergone a variety of changes. However, through it all, we’ve never strayed from the heart of our mission which is to provide the world with quality automated cell processing technologies and solutions. 35 years ago, Halley’s Comet last visited the Milky Way, Oprah Winfrey debuted her national … Continued
Innovation begins with curiosity – a desire to learn all that there is to know about a topic and then apply that knowledge for the benefit of others. Dr. Chris Xu, the CEO of ThermoGenesis Holdings Inc., is someone whose life-long curiosity has led to a mission of making life-saving therapies accessible to patients around … Continued
Cancer is the second leading cause of death in the United States behind heart disease according to the CDC. There are many kinds, but what they all have in common is that they start because of out-of-control growth of abnormal cells. For decades, scientists and medical professionals have researched this disease, and while a cure … Continued